BioArctic AB's partner Eisai has announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been la...
C2N Diagnostics, LLC and LSI Medience Corporation (LSIM) have announced a strategic partnership to pursue regulator...
Edesa Biotech, Inc., a Canada-based clinical-stage biopharmaceutical company focused on developing host-directed therape...
Japan-based Nxera Pharma has announced that its subsidiary, Nxera Pharma UK, has entered into an exclusive global licens...
Minghui Pharmaceutical and ASKA Pharmaceutical have entered into an exclusive license agreement for the development and ...
CellProthera, a clinical-stage company developing regenerative cell therapies for ischemic diseases, has announced its s...
Japan-based pharma firm Shionogi has announced that Shionogi China, a Shionogi group company in China, has entered into ...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.06 b...
PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development o...
Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) fi...
AI Proteins, Inc., a US-based biotechnology company that utilises computational de novo protein design to create therape...
NovAccel, Inc., a Japanese deep-tech company developing proprietary superconducting accelerator technology for medical r...
Japan-based TOHO HOLDINGS has invested in AdipoSeeds, Inc., a venture company spun off from Keio University School of Me...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
Forty years on, a different question When BioJapan opened its doors for the first time in 1986, Japan's pharmaceutical ...
ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...
Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...
Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...
If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIF...
Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...
Yokohama, 7 October 2026 | BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokoham...
Japan-based Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), l...
Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced...
Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing rou...
Reprocell Inc. has entered into a basic agreement with Toho Holdings toward a partnership concerning the domestic distri...
